Advanced Transplant Diagnostics And Immunogenetics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 63.83%
- Profit Growth -35.08%
- Ebitda -37.37%
- Net Worth 58.27%
- Total Assets 150.54%
About Advanced Transplant Diagnostics And Immunogenetics
Advanced Transplant Diagnostics And Immunogenetics Private Limited (ATDAIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 09 September 2019 (Five years and four months 21 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharat Shah, Shruti Tapiawala, Hepal Vora, and Two other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U93090MH2019PTC330328
- Company No.
330328
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2019
- Date of AGM
26 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Advanced Transplant Diagnostics And Immunogenetics?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shruti Tapiawala  | Director | 09-Sep-2019 | Current |
| Bharat Shah | Director | 09-Sep-2019 | Current |
| Hepal Vora | Director | 06-Nov-2020 | Current |
| Zaheer Virani | Director | 06-Nov-2020 | Current |
| Prashant Rajput | Director | 06-Nov-2020 | Current |
Financial Performance of Advanced Transplant Diagnostics And Immunogenetics.
Advanced Transplant Diagnostics And Immunogenetics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.83% increase. The company also saw a substantial fall in profitability, with a 35.08% decrease in profit. The company's net worth Soared by an impressive increase of 58.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Transplant Diagnostics And Immunogenetics?
In 2023, Advanced Transplant Diagnostics And Immunogenetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Centre For Digestive And Kidney Diseases (India) Private LimitedBharat Shah is a mutual person
Atdi Lab Private LimitedBharat Shah, Shruti Tapiawala and 3 more are mutual person
- Atdi Aurangabad Lab Private Limited
Bharat Shah, Shruti Tapiawala and 3 more are mutual person
- Maxxfresh Agro Farmer Producer Company Limited
Prashant Rajput is a mutual person
- La Naturelle Ferme India Private Limited
Prashant Rajput is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advanced Transplant Diagnostics And Immunogenetics?
Unlock and access historical data on people associated with Advanced Transplant Diagnostics And Immunogenetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Transplant Diagnostics And Immunogenetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Transplant Diagnostics And Immunogenetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.